Loading...
Loading...
Application UK00915683055 · Registered
| Application Number | UK00915683055 |
| Status | Registered |
| Owner | Centogene GmbH |
| Filed | 2016-07-21 |
| Registered | 2016-11-15 |
| Renewal Due | 2026-07-21 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
Yes. CentoScid is currently a registered UK trademark, with renewal due on 2026-07-21. It is protected under UK intellectual property law and can be enforced against infringing uses.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Diagnostic preparations; Diagnostic biomarker reagents for medical purposes; Preparations for detecting genetic predispositions for medical purposes; Nucleic acid sequences for medical and veterinary purposes.
Collating and systematic ordering of data in a computer database; Computerised file management.
Industrial analysis and research services; Research and development in the field of biotechnology; Genetic engineering services; Research and development in the field of diagnostics; Design and development of computer software and databases; Computer aided scientific research services, Testing and analysis services; Providing of information in the fields of pharmacology.
Conducting of medical tests for diagnostic or treatment purposes; Medical and health services relating to DNA, genetics and genetic testing; Genetic counseling; Medical laboratory services for the analysis of samples taken from patients; Providing of information in the fields of medicine and veterinary medicine.
'CentoScid' is a registered trademark on the UK IPO register, owned by Centogene GmbH. The application (UK00915683055) was filed on 21 July 2016 and registered on 15 November 2016. The registration is set to expire on 21 July 2026.
This mark is recorded under multiple classes: Class 5 (pharmaceuticals & medical preparations); Class 35 (advertising, business management & retail services); Class 42 (scientific, IT & design services); Class 44 (medical, veterinary & beauty services).
The trademark is represented by BOHMANN.
UK trademark UK00915683055 for the mark 'CentoScid' in Class 5, 35, 42, 44 is recorded on the UK IPO register as owned by Centogene GmbH. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Yes — the UK IPO records UK trademark UK00915683055 for the mark 'CentoScid' as registered.
UK trademark UK00915683055 for the mark 'CentoScid' is recorded in Class 5 (pharmaceuticals & medical preparations); Class 35 (advertising, business management & retail services); Class 42 (scientific, IT & design services); Class 44 (medical, veterinary & beauty services). The filed specification reads: Class 5: Diagnostic preparations; Diagnostic biomarker reagents for medical purposes; Preparations for detecting genetic predispositions for medical purposes; Nucleic acid sequences for medical and veterinary purposes. | Class 35: Collating and systematic ordering of data in a computer database; Computerised file ma…
UK trademark UK00915683055 for the mark 'CentoScid' was filed at the UK IPO on 21 July 2016 and registered on 15 November 2016.
UK trademark UK00915683055 for the mark 'CentoScid' is currently recorded as valid until 21 July 2026, at which point it will need to be renewed with the UK IPO to remain in force.
BOHMANN is listed as the attorney / representative of record for UK trademark UK00915683055 for the mark 'CentoScid' on the UK IPO register.
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.